Completed NA INTERVENTIONAL 5-arm NCT04465851

Effect of Ferrous iROn and cUrcumin sTatus on Inflammatory and Neurotrophic markErs (Fe-ROUTINE)

The Effect of HydroCurc™ Curcumin and Ferrous Iron Supplementation on Iron Status and Inflammatory and Neurotrophic Marker Levels in Healthy Adults

Sponsor: Gencor Pacific Group

Conditions Iron Deficiency (Without Anemia)

Interventions Curcumin Ferrous Sulphate 18mg Ferrous Sulphate 65 mg Placebo (Curcumin) Placebo (Ferrous Sulphate)

Updated 4 times since 2020 Last updated: Jul 6, 2020 Started: Jul 18, 2018 Primary completion: Nov 11, 2019 Completion: Jan 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Iron Deficiency (Without Anemia) and is currently completed. Gencor Pacific Group leads this study, which shows 4 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Aug 2020 — Jan 2021 [monthly]

Completed NA

First recorded

Jul 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gencor Pacific Group
University of Westminster

Data source: University of Westminster

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom